User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

1124

Interactions with Platform & by Email *

INTERACTIONS

202

Unique # Participated *

PARTICIPANTS

45

Responses Validated *

VALIDATIONS

11

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Computer Aided Detection - Offering “Second Look” for Radiology Analysis.....II-1
The Need for Early Disease Diagnosis and the Role of CAD.....II-1
1$75
   Table 1: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-21$350
   Market Highlights.....II-3
Major Drivers & Restraints.....II-3
1$75
   Breast CAD to Hold its Forte in the CAD Market.....II-41$75
   Recession in Retrospect and the Road Ahead.....II-5
Improving Healthcare Expenditure to Foster Growth.....II-5
1$75
   Table 2: Per-Capita Healthcare Expenditure in US$ for Select Regions: 2014 (includes corresponding Graph/Chart).....II-6

Table 3: Healthcare Spending as a Percentage of GDP in Select Developing Countries (2014E) (includes corresponding Graph/Chart).....II-6

Table 4: Healthcare Spending as a Percentage of GDP in Select Developed Countries for 2004, 2008 & 2014E (includes corresponding Graph/Chart).....II-6
1$350
   Table 5: Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP: 2014E (includes corresponding Graph/Chart).....II-71$350
   From “Second Reader” to “First Reader” Use - the Unconquered Avenue of CAD
  Systems.....II-8
CAD Use Rises despite Controversies.....II-8
1$75
   Replacements to Fuel Market Growth.....II-9
High Dependence on Related Modality Continues.....II-9
Market Calls for Higher Efficiencies in CAD.....II-9
Product Developments Underway to Expand Utility.....II-9
1$75
   Information Provision - A Key Feature under Development for Enhanced
  Efficiency.....II-10
1$75
   Research finds Interactive Use of CAD More Efficient.....II-11
Rising Incidence of Cancer - A Major Market Driver.....II-11
Cancer Prone Sites based on Age.....II-11
1$75
   World Cancer Statistics - Incidence and Mortality Data.....II-12
Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).....II-12
1$350
   Table 7: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer- Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).....II-13

Table 8: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart).....II-13
1$350
   Table 9: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart).....II-14

Table 10: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart).....II-14

Table 11: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart).....II-14
1$350
   Table 12: World Breast Cancer Statistics (2012): Top 20 Countries with Highest Breast Cancer Rates (includes corresponding Graph/Chart).....II-151$350
   iCAD - A Leading Independent Player in the Mammography CAD Segment.....II-161$75
   Present Applications of CAD.....II-17
What Lies Ahead at the Application Front?.....II-17
CAD in Breast Cancer.....II-17
CAD Simplifies Breast MRI Image Analysis; Tremendous Scope for Adoption Ahead.....II-17
1$75
   Breast MRI - Lagging behind Mammography in Cancer Detection.....II-18
CAD Solutions for Breast Cancer.....II-18
SecondLook Digital (iCAD).....II-18
R2 ImageChecker (Hologic, Inc.).....II-18
SpectraLook CAD Solution (iCAD).....II-18
1$75
   DynaCAD Breast (Invivo).....II-19
CADstream Breast MRI Application (Merge Healthcare).....II-19
List of Select Approved CAD Solutions for Breast MRI.....II-19
CAD in Prostate Cancer.....II-19
1$75
   CAD in Lung Cancer.....II-20
The Background.....II-20
1$75
   An Overview of CAD Solutions for Lung Cancer Detection.....II-21
IQQA (EDDA Technology).....II-21
ClearRead +Detect™ (formerly OnGuard) (Riverain Technologies).....II-21
xLNA (Philips).....II-21
1$75
   syngo CAD Solutions (Siemens).....II-22
CAD in Liver Cancer.....II-22
CAD Solutions for Liver Cancer Detection.....II-22
CADstream (Merge Healthcare).....II-22
IQQA (EDDA Technology).....II-22
CAD in the Detection of Prostate Cancer.....II-22
1$75
   Available CAD Solutions for Prostate Cancer.....II-23
CAD in the Detection of Colon Cancer.....II-23
1$75
   CAD in Cardiology.....II-24
Increasing Need for CAD in Cardiology.....II-24
Table 13: Cardiovascular Disease Incidence in the US by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart).....II-24
Automatic Workflow Integration Fuels Demand for Cardiac CAD.....II-24
1$350
   Significant Hurdles Exist for CAD in Cardiology.....II-251$75
   Regional Perspective.....II-261$75
   A. Market Analysis.....II-26
Current & Future Analysis.....II-26
Challenges in Evaluation Dents Approvals of New CAD Systems.....II-26
1$75
   Final Guidance Documents on CAD offers Respite to Industry Players.....II-27
CAD Devices, as Defined by the FDA.....II-27
1$75
   Guidance on 510(k) Application.....II-28
FDA’s FFDM Reclassification to Benefit CAD Market.....II-28
Competition.....II-28
Table 14: The US Mammography CAD Market by Leading Player: 2014 (includes corresponding Graph/Chart).....II-28
1$350
   Select FDA Approved CAD Software: 2001-2013.....II-29
Ageing Demographics: A Key Market Driver.....II-29
1$75
   Table 15: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-30
Rising Cancer Incidence, and the Need for Early Detection Propel Market
  Growth.....II-30
1$350
   Table 16: New Cancer Cases in the US by State: 2014.....II-312$700
   Table 17: New Cancer Cases in the US by Gender and Affected Site: 2014.....II-332$700
   Table 18: Cancer Related Deaths in the US by Gender and Body Site: 2014.....II-352$700
   Table 19: Cancer Mortality in the US by Site for Male and Female Populations (2013): Breakdown of Number of Deaths for Breast, Lung & Bronchus, Colon & Rectum, Liver & Bile Duct, Prostate and Other Cancers (includes corresponding Graph/Chart).....II-37
CAD to Gain from Rapid Growth in CTC Volumes.....II-37
1$350
   Physicians’ Reluctance to Follow USPSTF - A Shot in the Arm for CAD
  Manufacturers.....II-38
Mammography and Breast MRI, and CAD Reimbursement in the US.....II-38
CMS Coverage for Screening and Diagnostic Mammography and Breast MRI - A
  Review.....II-38
1$75
   Table 20: Medicare Reimbursement Codes and Allowable Rates for CAD in Mammography: 2012-2014.....II-39
Low and Spotty Reimbursement Mars CAD in Prostate Cancer Detection.....II-39
No Separate Codes for CAD in Prostate MRI.....II-39
1$350
   B. Market Analytics.....II-40
Value Analytics.....II-40
Table 21: The US Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-40
1$350
   Table 22: The US Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2012 (includes corresponding Graph/Chart).....II-411$350
   Table 23: The US 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Dollar Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart).....II-421$350
   Volume Analytics.....II-43
Table 24: The US Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in Units for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-43
1$350
   Table 25: The US Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2012 (includes corresponding Graph/Chart).....II-441$350
   Table 26: The US 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Unit Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart).....II-451$350
   A. Market Analysis.....II-46
Economic Woes Dampen European CAD Market Prospects.....II-46
Long-Term Prospects Appear Brighter.....II-46
Breast CAD Dominates, Other Applications to Witness Fastest Growth.....II-46
1$75
   Rising Incidence of Cancer.....II-47 1$75
   Table 27: European Cancer Incidence by Geographic Region (2012): Number of New Cancer Cases Reported in Thousands for Western Europe, Northern Europe, Southern Europe, and Central & Eastern Europe (includes corresponding Graph/Chart).....II-48

Table 28: Cancer Incidence in Western Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Prostate, Breast, Colorectal, Lung and Other Cancers (includes corresponding Graph/Chart).....II-48
1$350
   Table 29: Cancer Incidence in Northern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Breast, Prostate, Colorectal, Lung and Other Cancers (includes corresponding Graph/Chart).....II-49

Table 30: Cancer Incidence in Southern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Colorectal, Breast, Lung, Prostate and Other Cancers (includes corresponding Graph/Chart).....II-49

Table 31: Cancer Incidence in Central and Eastern Europe by Site (2012): Number of New Cancer Cases Reported in Thousands for Lung, Colorectal, Breast, Stomach and Other Cancers (includes corresponding Graph/Chart).....II-49
1$350
   Ageing Population Boosts Demand for Computer Aided Detection.....II-50
Table 32: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....II-50
1$350
   B. Market Analytics.....II-51
Value Analytics.....II-51
Table 33: European Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-51
1$350
   Table 34: European Historic Review for Computer Aided Detection (CAD) by Application - Breast, Chest and Other CAD Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2012 (includes corresponding Graph/Chart).....II-521$350
   Table 35: European 14-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Dollar Sales for Breast, Chest and Other CAD Markets for Years 2007, 2014 and 2020 (includes corresponding Graph/Chart).....II-531$350
   Volume Analytics.....II-54
Table 36: European Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) Market Analyzed with Annual Sales Figures in Units for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-54
1$350
   Table 37: European Historic Review for Computer Aided Detection (CAD) Market Analyzed with Annual Sales Figures in Units for Years 2007 through 2012 (includes corresponding Graph/Chart).....II-551$350
   CAD - An Introduction.....II-56
A Brief History of CAD.....II-56
Methodology.....II-56
1$75
   Sensitivity / Specificity.....II-57
Absolute Detection Rate.....II-57
Applications of Computer-Aided Detection.....II-57
Breast Cancer.....II-57
Lung Cancer (Bronchial Carcinoma).....II-57
1$75
   Evolution of Computer-Aided Detection for Mammography.....II-58
CAD Technology - Working Operation.....II-58
1$75
   Existing Limitations of CAD.....II-591$75
   VuCOMP Obtains Market Clearance for M-Vu® CAD and M-Vu Breast Density in
  Turkey.....II-60
VuCOMP Receives US FDA Approval for M-Vu CAD for Mammography Version 3.1.....II-60
iCAD Obtains FDA Clearance for Mammography CAD Platform.....II-60
VuCOMP Receives Premarket Approval from FDA for M-Vu Film Mammography CAD.....II-60
iCAD Introduces Advanced Mammography CAD System.....II-60
Parascript Unveils Updated AccuDetect CAD Technology.....II-60
1$75
   iCAD Expands Existing Partnership with Volpara Solutions.....II-61
Salient Imaging Takes Over Medipattern.....II-61
Real Time Tomography Inks Licensing Agreement with im3D.....II-61
iCAD and Invivo Ink Agreement.....II-61
Planmed and Three Palm Software Ink Partnership Agreement.....II-61
Sectra Signs Agreement with Merge Healthcare.....II-61
1$75
   EDDA Technology, Inc. (US).....II-62
Hologic, Inc. (US).....II-62
1$75
   iCAD, Inc. (US).....II-632$150
   Invivo Corp. (US).....II-65
Merge Healthcare, Inc. (US).....II-65
1$75
   Riverain Technologies (US).....II-661$75
   Salient Imaging, Inc. (US).....II-67
Siemens Healthcare (Germany).....II-67
1$75
   VuCOMP Inc. (US).....II-681$75
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com